MARCAR

Identification of early biological indicators for predicting non-genotoxic carcinogenic effects

Description

The aim of the project is to identify early biological indicators to predict the effects of non-genotoxic carcinogens

Period:
01.01.2010 - 31.12.2014
FKZ:
-
Funding:
Europäische Union Innovative Medicines Initiative (IMI)

Projectlead

Dr. Markus Templin

Group Leader Assay Development

+49 7121 51530-828
Contact via email
Show CV

NMI Natural and Medical Sciences Institute
at the University of Tübingen
Markwiesenstraße 55, 72770 Reutlingen
Tel.: +49 7121 51530-0
Mail: info@nmi.de

Follow us now

Subsidiary company
Member of
Member of